싱가포르 - 영어 - HSA (Health Sciences Authority)

baxter healthcare (asia) pte ltd - furosemide - injection, solution - furosemide 20 mg/2 ml

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - furosemide 10mg - solution for injection - 10 mg/ml - active: furosemide 10mg excipient: hydrochloric acid sodium hydroxide ph adjustment sodium chloride sodium hydroxide water for injection - furosemide-baxter injection is indicated in adults, infants and children for the treatment of oedema associated with congestive heart failure, cirrhosis of the liver and renal disease including the nephrotic syndrome. furosemide is particularly useful when an agent with greater diuretic potential than that of those commonly employed is desired. parenteral therapy should be reserved for patients unable to take oral medication or for patients in emergency clinical situations.

유럽 연합 - 영어 - EMA (European Medicines Agency)

baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastic agents - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma.non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.1).pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5.1).pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.1).

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - irinotecan hydrochloride -

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - paclitaxel -

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - chlorhexidine acetate, quantity: 5 mg/ml - solution, irrigation - excipient ingredients: cetrimide; glacial acetic acid; water for injections; methylene blue - chlorhexidine acetate (0.5 %) antiseptic solution is used as a general antiseptic. it is used for the cleaning and disinfecting of wounds and the antiseptic treatment of burns.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - chlorhexidine acetate, quantity: 1 mg/ml - solution, irrigation - excipient ingredients: water for injections; glacial acetic acid; methylene blue - chlorhexidine acetate (0.1 %) antiseptic solution is used as a general antiseptic. it is used for the cleaning and disinfecting of wounds and the antiseptic treatment of burns.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - chlorhexidine acetate, quantity: 0.5 mg/ml - solution, irrigation - excipient ingredients: glacial acetic acid; methylene blue; water for injections - chlorhexidine acetate (0.5 %) antiseptic solution is used as a general antiseptic. it is used for the cleaning and disinfecting of wounds and the antiseptic treatment of burns.

말레이시아 - 영어 - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

baxter healthcare (malaysia) sdn. bhd. - sodium lactate; dextrose anhydrous ip; sodium chloride ip; calcium chloride ip; magnesium chloride ip -

말레이시아 - 영어 - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

baxter healthcare (malaysia) sdn. bhd. - dextrose anhydrous ip; sodium chloride ip; sodium lactate; calcium chloride ip; magnesium chloride ip -